Education
About Us
Working with TipRanks
Follow Us
Knight Therapeutics (TSE:GUD)
TSX:GUD
| Dec 24 | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | C$ 371.30M | C$ 328.20M | C$ 293.56M | C$ 243.48M | C$ 199.52M |
| Gross Profit | C$ 174.41M | C$ 152.65M | C$ 138.06M | C$ 115.41M | C$ 81.69M |
| Operating Income | C$ 7.40M | C$ -2.89M | C$ -2.40M | C$ -5.32M | C$ -3.44M |
| EBITDA | C$ 64.38M | C$ 40.90M | C$ 25.26M | C$ 42.59M | C$ 67.56M |
| Net Income | C$ 4.33M | C$ -16.84M | C$ -29.89M | C$ 15.68M | C$ 31.76M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | C$ 172.84M | C$ 154.42M | C$ 185.61M | C$ 162.99M | C$ 411.34M |
| Total Assets | C$ 963.80M | C$ 945.49M | C$ 1.05B | C$ 991.89M | C$ 1.04B |
| Total Debt | C$ 49.46M | C$ 69.09M | C$ 77.70M | C$ 40.96M | C$ 56.19M |
| Net Debt | C$ -30.65M | C$ 10.33M | C$ 6.02M | C$ -45.01M | C$ -173.40M |
| Total Liabilities | C$ 168.69M | C$ 198.62M | C$ 228.98M | C$ 149.87M | C$ 153.44M |
| Stockholders' Equity | C$ 795.11M | C$ 746.87M | C$ 825.86M | C$ 842.02M | C$ 886.24M |
| Cash Flow | |||||
| Free Cash Flow | C$ 4.81M | C$ 25.98M | C$ 14.66M | C$ -179.56M | C$ -32.87M |
| Operating Cash Flow | C$ 36.28M | C$ 35.94M | C$ 40.48M | C$ 44.62M | C$ -12.21M |
| Investing Cash Flow | C$ 16.96M | C$ 29.34M | C$ -63.08M | C$ -105.28M | C$ 101.35M |
| Financing Cash Flow | C$ -33.54M | C$ -81.00M | C$ 1.76M | C$ -78.31M | C$ -29.23M |